ASNC: Novel Imaging Agent Safe in Airway Disease Patients – MedPage Today

ASNC: Novel Imaging Agent Safe in Airway Disease Patients
MedPage Today
PHILADELPHIA — A novel pharmacologic stress agent for myocardial perfusion imaging, apadenoson (Stedivaze), was well tolerated in patients with asthma and
Lexiscan® (Regadenoson) Injection Study in Subjects With Asthma or Chronic PR Newswire (press release)

all 12 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.